Colorectal Cancer Screenings. The Plan provides Benefits for colorectal cancer screenings as described in the guidelines of a national cancer society for asymptomatic Members who are:
Colorectal Cancer Screenings. The Plan provides Benefits for colorectal cancer screenings for asymptomatic Members who are:
a. At average risk for colorectal cancer or
b. At high risk for colorectal. For purposes of this section, “Colorectal Cancer Screening” means all colorectal cancer examinations and FDA-approved laboratory tests recommended by a Provider in accordance with the most recently published nationally recognized evidence based clinical guidelines. If a colonoscopy is recommended as the colorectal cancer screening method and a lesion is discovered and removed during the colonoscopy, Benefits will be paid for the screening colonoscopy as the primary procedure. See section 2.I for information about free preventive services as defined in federal law. Preventive colonoscopies without cost-sharing are only eligible for Members who meet the specific guidelines under the USPSTF. See section 4.B.62 Preventive Care for further information on preventive services. Colorectal cancer evaluations for asymptomatic screenings may be considered preventive (age dependent), but colorectal cancer evaluations due to symptoms or suspected disease are considered diagnostic and are subject to routine plan cost- sharing.
Colorectal Cancer Screenings. Grantee will work with identified health system/clinic to implement at least two of the following evidence-based interventions related to increasing colorectal cancer screenings among adults aged 50 to 75. Grantee shall utilize:
